Low-Dose Streptozotocin Induces Sustained Hyperglycemia in Macaca nemestrina

References

• Palmer J, Lernmark P. A. Pathophysiology of type I (Insulin-Dependent) diabetes. Ellenberg and Rifkin's Diabetes Mellitus Theory and Practice 4th edn. cd., H. DP Rifkin. Elsevier, New York 1990; 414
   Google Scholar
• Pipeleers Ling D.Z. Pancreatic beta cells in insulin-dependent diabetes. Diabetes Metabolism Reviews 1992; 8: 209
   PubMed Web of Science ®Google Scholar
• Aguilo F, Jr. Islet cell transplantation [editorial]. Bol Asoc MedPR 1979; 71(7)267
   PubMedGoogle Scholar
• Eloy R, Haffen K, Kedinger M, Michel F, Bouchet P, Grenier J F. [Islet cell transplantation and diabetes (author's transl)]. Nouv Presse Med 1979; 8(14)1171
   PubMedGoogle Scholar
• Like A, Rossini A. A A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976; 193: 415
   PubMed Web of Science ®Google Scholar
• Bonnevie-Nielsen V, Lernmark A. An H-2 alloantiscrum preserves beta-cell function in mice made diabetic by low-dose streptozocin. Diabetes 1986; 35(5)570
   PubMedGoogle Scholar
• Rossini A A, Faustman D, Woda B A, Like A A, Szymanski I, Mordes J P. Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat. J Clin Invest 1984; 74(1)39
   PubMedGoogle Scholar
• Rossini A A, Williams R M, Appel M C, Like A A. Complete protection from low-dose streptozotocin-induce diabetes in mice. Nature 1978; 276: 182
   PubMed Web of Science ®Google Scholar
• Leiter E. Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus. Proc Natl Acad Sci U S A. 1982; 79(2)630
   PubMed Web of Science ®Google Scholar
• Bonnevie-Nielsen V, Steffes M W, Lernmark Å. A major loss in islet mass and |3-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin. Diabetes 1981; 30: 424
   PubMed Web of Science ®Google Scholar
• KieselKolb U. H. Suppressive effect of antibodies to immune response gene products on the development of low-dose streptozotocin-induced diabetes. Diabetes 1983; 32: 869
   PubMedGoogle Scholar
• Kim Y T, Steinberg C. Immunologic studies on the induction of diabetes in experimental animals: cellular basis for the induction of diabetes by streptozotocin. Diabetes 1984; 33: 771
   PubMed Web of Science ®Google Scholar
• Nedergaard M, Egeberg J, Kromann H. Irradiation protects against pancreatic islet degeneration and hyperglycemia following streptozotocin treatment of mice. Diabelologia 1983; 24(5)382
   PubMedGoogle Scholar
• Blue M L, Shin S I. Diabetes induction by subdiabetogenic doses of streptozotocin in BALB/cBOM mice: noninvolve-ment of host B-lymphocyte functions. Diabetes 1984; 33: 105
   PubMedGoogle Scholar
• Herold K, Montag A, Fitch F. Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozocin. Diabetes 1987; 36(7)796
   PubMedGoogle Scholar
• Paik S G, Fleischer N, Shin S. Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated immune process. Proc. Natl. Acad. Sci. 1980; 77: 6129
   PubMed Web of Science ®Google Scholar
• Buschard K, Rygaard J. Passive transfer of streptozotocin induced diabetes mellitus with spleen cells. Acta Pathol Microbiol Scand 1977; 85(C)469
   Google Scholar
• Paik S G, Blue M L, Fleischer N, Shin S I. Diabetes susceptibility of BALB/cBOM mice treated with streptozotocin: inhibition by lethal irradiation and restoration by splenic lymphocytes. Diabetes 1982; 31: 808
   PubMedGoogle Scholar
• Jones C W, Reynolds W A, Haganson E. Streptozotocin diabetes in the monkey. Plasma levels of glucose, insulin, glyco-gon and somatostatin with corresponding morhpometric analysis of islet endocrine cells. Diabetes 1980; 29: 536
   PubMedGoogle Scholar
• Jonasson O, Jones C W, Bauman A, John E. The pathophysiology of experimental insulin-deficient diabetes in the monkey. Implications for pancreatic transplantations. Ann. Surg. 1985; 201: 27
   PubMedGoogle Scholar
• McCulloch D K, Raghu P K, Johnston C. Defects in β-cell function and insulin sensitivity in normoglycemic streptozo-cin-treated baboons: a model of preclinical insulin-dependent diabetes. J. Clin. Endocrinol. Met. 1988; 67: 785
   PubMedGoogle Scholar
• Miller S A, Dykes D D, Polesky H F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215
   PubMed Web of Science ®Google Scholar
• Gaur L K, Pandarpurkar M, Anderson J. DQA-DQB linkage in Old World monkeys. Tissue Antigens 1998; 51(4 Pt 1)367
   PubMedGoogle Scholar
• LeBlanc. On diabete chez lex animaux. Clinique Veterinaire(Lyon). 1851; 225
   Google Scholar
• Du Toit D F, Heydenrych J J, Smit B, Zuurmond T, Louw G, Laker L, Els D, Weideman A, Wolfe-Coote S, Du Toit L B, et al. The effect of ionizing radiation on the primate pancreas: an endocrine and morphologic study. J. Surg Oncol 1987; 34(1)43
   PubMedGoogle Scholar
• Kenyon N S, Fernandez L. A., Lehmann R, Masetti M, Ranun-Coli A, Chatzipetrou Mea. Long-term Survival and Funciton of Intrahepatic Islet Allografts in baboons treated with Humanized Anti-CD 154. Diabetes 1999; 48: 1473
   PubMed Web of Science ®Google Scholar
• Levisetti M G, Padrid P A, Szot G L, Mittal N, McEhan S M, Wardrip C L, Gray G S, Bruce D S, Thistlethwaite J R, Jr., Bluestone J A. Immunosuppressive effects of human CTLA41g in a non-human primate model of allogeneic pancreatic islet transplantation. J Immunol 1997; 159(11)5187
   PubMed Web of Science ®Google Scholar
• Theriault B R, Thislethwaite J R, jr, Levisetti M G, Szot L., Wardrip C G, Bruce DSea. Induction, maintenance, and reversal of Streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascicularis). Transplantation 1999; 68(3)331
   PubMed Web of Science ®Google Scholar
• Stegall M D, Chabot J, Weber C, Reemtsma K, Hardy M A. Pancreatic islet transplantation in cynomolgus monkeys. Initial studies and evidence that cyclosporine impairs glucose tolerance in normal monkeys. Transplantation 1989; 48(6)944
   PubMedGoogle Scholar
• Takimoto G, Jones C, Lands W, Bauman A, Jeffrey J, Jonas-Son O. Biochemical changes in rhesus monkey during the first days after streptozotocin administration are indicative of selective beta cell destruction. Metabolism 1988; 37(4)364
   PubMedGoogle Scholar
• Pitkin R M, Reynolds W A. Diabetogenic effects of streptozotocin in rhesus monkeys. Diabetes 1970; 19(2)85
   PubMedGoogle Scholar
• Kiesel U, Kolb H. Low-dose streptozotocin-induced autoimmune diabetes is under the genetic control of the major histocompatibility complex in mice. Diabetologia 1982; 23(1)69
   PubMedGoogle Scholar
• Tanaka S, Nakajima S, Inoue S, Takamura Y, Aoki I, Okuda K. Genetic control by 1-A subregion in H-2 complex of incidence of streptozocin-induced autoimmune diabetes in mice. Diabetes 1990; 39(10)1298
   PubMedGoogle Scholar
• Gaur L K, Hughes A L, Heise E R, Gutknccht J. Maintenance of DQB1 polymorphisms in primates. Mol Biol Evol 1992; 9(4)599
   PubMedGoogle Scholar
• Gaur L K, Nepom G T. Ancestral MHC-DRB genes beget conserved patterns of localized polymorphisms. Proc. Natl. Acad. Sci. USA 1996; 93: 5380
   PubMedGoogle Scholar
• Gaur L K, Nepom G T, Snyder K E, Anderson J, Pandarpurkar M, Yadock W, Heise E R. MHC-DRB allelic sequences incorporate distinct intragenic trans- specific segments. Tissue Antigens 1997; 49(4)342
   PubMedGoogle Scholar
• Rossini A A, Appel M C, Williams R M, Like A A. Genetic influence of the steptozotocin-induced insulilis and hyperglycemia. Diabetes 1977; 26: 916
   PubMed Web of Science ®Google Scholar
• Harold K C, Monlag A G, Fitch F. W. Treatment with anti–T-lymphocyte antibodies prevents induction of insulitis in mice. given multiple doses of strepto/otocin. Diabetes 1987; 36: 786
   Google Scholar